Controlant and SmartCAE to transform lane risk assessment and thermal packing selection in pharma

Balancing patient safety, costs, and environmental footprint

Thermal packaging for temperature-sensitive drugs is a balancing act of safety, cost, and carbon emission goals. If packaging isn’t up to the task, life-saving medicines could lose their efficacy due to temperature fluctuations, creating serious consequences for patients and potential stock-outs of medicines. Overengineering, on the other hand, adds unnecessary costs and excessive carbon footprint, wasting valuable resources.

Smarter packaging selection

In partnership, Controlant and SmartCAE look to solve both sides of the equation by helping pharma companies and logistics providers make smarter and greener data-driven decisions.

By integrating Controlant’s real-time data from its IoT loggers—capturing detailed information about shipment conditions, including temperature, and location—with SmartCAE’s advanced simulations, pharmaceutical companies can make more informed decisions on packaging as well as routes and services.

Real data to drive real results

"Our collaboration with SmartCAE is another step forward in our mission to transform pharma supply chains, combining our extensive pharma and technological expertise,” said Gísli Herjólfsson, CEO and co-founder at Controlant. “With this partnership and by leveraging real-time data from our IoT loggers, we enable our customers to lower costs, protect patients, and reduce waste by making data-driven decisions on optimal thermal packaging. Ultimately, this propels us forward on our ambition towards zero-waste pharma supply chains.”

“SmartCAE sees collaboration between different stakeholders in the industry as key to making cold chains safer, greener, and more cost efficient,” says Stefan Braun, Managing Director and founder of SmartCAE. Our Digital Twin technology and real-time IoT loggers provide more insights to drive faster, data-driven decisions about the right packaging for a given lane.”

Pioneering the future of cold chain management

This integrated approach enables continuous evaluation of the costs, risks, and environmental impacts of thermal packaging and logistics. Customers can then adjust their packaging strategies to seasonal variations and real-world conditions when managing temperature-sensitive products across a complex distribution network, ensuring safe and effective delivery of pharmaceutical products.

The collaboration will be highlighted at the upcoming HPCLC Fall 2024 conference, 14-16 October, where Roche, Controlant, and SmartCAE will showcase their joint efforts to revolutionize cold chain logistics for the pharmaceutical industry.

About SmartCAE

SmartCAE provides simulation software for cold chain logistics. Their Digital Twin platform enables companies to perform temperature simulations that assess risks associated with thermal packaging solutions. By combining real-world data with advanced modeling techniques, SmartCAE helps businesses optimize packaging strategies, reduce costs, and ensure the safe delivery of temperature-sensitive products.

About Controlant

Controlant is a global leader in the digital transformation of pharma supply chains. Its vision is to deliver zero-waste supply chains for our partners and the planet through digitalization, automation, and transformation of the pharma supply chain. The company’s validated real-time visibility platform, command center, services, and advanced IoT devices, are trusted by many of the world's leading pharmaceutical and logistics companies to make their operations significantly more reliable, cost-effective, and sustainable. Ultimately, Controlant’s solutions help get life-saving medicines to more patients, curing more diseases. Founded in 2007, Controlant’s team includes 290 people and the company generated USD 185 million in revenues in 2023. More information at controlant.com.

SmartCAE media contact: publicrelations@smartcae.de

Controlant media contact: press@controlant.com